Mithra Pharmaceuticals

Mithra Pharmaceuticals SA specializes in the development of women's health products, focusing on contraception, fertility, and menopause. Its two main development candidates, Estelle® (the fifth-generation oral contraceptive) and Donesta® (the next-generation hormone therapy), are both built on Mithra's unique natural estrogen platform E4 (Estetrol).